OTC · Financial Statements
Ceryvyn Therapeutics Limited (CKDXF) Financial Statements
$0.01
OTC: CKDXF
Market Cap $13.68M
Overview Financials Dividend Ceryvyn Therapeutics Limited most recently reported annual revenue of $0, net profit of $-163.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-40.0M $-97.0M $-150.0M $-192.0M $-156.0M Net Profit $-61.0M $-128.0M $-212.0M $-220.0M $-163.0M EPS $-0.18 $-0.34 $-0.45 $-0.35 $-0.13 Op Margin -43098.0% -77201.3% -138912.0% -153885.4% -613622.8%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $184.0M $87.0M $148.0M $189.0M $57.0M Total Liabilities $4.0M $18.0M $157.0M $265.0M $258.0M Cash $157.0M $65.0M $134.0M $172.0M $48.0M Borrowings $0 $0 $86.0M $142.0M $248.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-61.0M $-98.0M $-179.0M $-161.0M $-159.0M Investing Cash Flow $1.0M $0 $0 $0 $0 Financing Cash Flow $-40.0M $0 $-81.0M $85.0M $0 Net Cash Flow $76.0M $-74.0M $45.0M $83.0M $-124.0M Free Cash Flow $-61.0M $-98.0M $-179.0M $-161.0M $-159.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.13 FCF Yield -768.23% Quick Ratio 19.52 Interest Coverage -0.97 Return 1Y -97.73% Return 3Y -97.62% Return 5Y —
Screens featuring this stock